S100A9 was also shown to suppress erythroid differentiation in both experimentally induced deletion 5q subtype of myelodysplastic syndrome through inactivation of Rps14 and wild-type mouse model, specifically the hematopoietic stem cells and progenitor cells [29]. Here, RPS14 is linked to myelodysplastic syndrome.